Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ferroportin Disease”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Early research (Phase 1)Study completedNCT06726863
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults

Who this might be right for
Healthy Volunteers
CSL Behring 22
Very early researchStudy completedNCT01988116
What this trial is testing

Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAnemia of Chronic Disease
University of Alabama at Birmingham 40
Testing effectiveness (Phase 2)Study completedNCT01949467
What this trial is testing

Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.

Who this might be right for
Hemochromatosis, Type 4Ferroportin DiseaseDysmetabolic Hepatosiderosis+1 more
Rennes University Hospital 62
Large-scale testing (Phase 3)Study completedNCT01414374
What this trial is testing

Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency

Who this might be right for
Iron Deficiency Anemia
Casa Espirita Terra de Ismael 50
Early research (Phase 1)Study completedNCT01330953
What this trial is testing

A First Human Study of a Ferroportin Antibody

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 32
Testing effectiveness (Phase 2)Looking for participantsNCT07332091
What this trial is testing

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

Who this might be right for
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
CSL Behring 84